Temporal changes in risk of cardiovascular events in people with newly diagnosed type 2 diabetes with and without cardiovascular disease-Reference-Cited by-同舟云学术

Temporal changes in risk of cardiovascular events in people with newly diagnosed type 2 diabetes with and without cardiovascular disease

Published:2022-02 Issue:2 Volume:36 Page:108126
ISSN:1056-8727
Container-title:Journal of Diabetes and its Complications
language:en
Short-container-title:Journal of Diabetes and its Complications

Author:

Nørgaard Caroline H.,Starkopf Liis,Gerds Thomas A.,Malmborg Morten,Bonde Anders N.,Zareini Bochra,Mills Elisabeth Helen Anna,Vestergaard Peter,Wong Nathan D.,Torp-Pedersen Christian,Lee Christina J.-Y.

Funder

Bayer Fund

Novo Nordisk

Hjerteforeningen

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference43 articles.

1. Mortality and cardiovascular disease in type 1 and type 2 diabetes;Rawshani;N Engl J Med,2017

2. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: A collaborative meta-analysis of 102 prospective studies;Lancet,2010

3. 10. Cardiovascular disease and risk management: standards of medical care in diabetes - 2019;ADA;Diabetes Care,2019

4. Impact of diabetes mellitus on hospitalization for heart failure, cardiovascular events, and death: outcomes at 4 years from the reduction of atherothrombosis for continued health (REACH) registry;Cavender;Circulation,2015

5. Incidence of hospitalization for heart failure and case-fatality among 3.25 million people with and without diabetes mellitus;McAllister;Circulation,2018

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk stratification for cardiovascular disease based on prior coronary artery disease, cerebrovascular disease and type 2 diabetes mellitus;Journal of Diabetes Investigation;2024-08

2. Overweight and obesity are associated with better survival in STEMI patients with diabetes;Obesity;2023-09-10

3. Synthesis, biological evaluation, and molecular docking study of chromen‐linked hydrazine carbothioamides as potent α‐glucosidase inhibitors;Drug Development Research;2023-04-26

4. Risk Stratification for Cardiovascular Disease Based on Prior Coronary Artery Disease, Cerebrovascular Disease and Diabetes Mellitus;2023-01-09

5. Neuro-vascular coupling and heart rate variability in patients with type II diabetes at different stages of diabetic retinopathy;Frontiers in Medicine;2022-11-10